We are live on
!
Find out more
CP
Covenant Partners Portfolio holdings
AUM
$342M
1-Year Est. Return
19.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.23%
1 Year Est. Return
+19.24%
3 Year Est. Return
+70.32%
5 Year Est. Return
+79.29%
10 Year Est. Return
–
AUM
$324M
AUM Growth
-$19.1M
(-5.6%)
Cap. Flow
-$15M
Cap. Flow
% of AUM
-4.62%
Top 10 Holdings %
Top 10 Hldgs %
68.58%
Holding
184
New
7
Increased
19
Reduced
72
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE Value ETF
EFV
|
+$2.11M |
| 2 |
iShares MSCI EAFE Growth ETF
EFG
|
+$2.11M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.74M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.4M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$541K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$4.04M |
| 2 |
Merck
MRK
|
+$1.34M |
| 3 |
Union Pacific
UNP
|
+$1.08M |
| 4 |
iShares Russell 2000 Value ETF
IWN
|
+$911K |
| 5 |
Prologis
PLD
|
+$903K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.39% |
| 2 | Financials | 6.68% |
| 3 | Healthcare | 4.39% |
| 4 | Industrials | 3.89% |
| 5 | Consumer Discretionary | 3.77% |
Similar funds
SHFA
YCG
TAM
LODC
OFS
MWM
PPH
TPW
Covenant Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Covenant Partners held 184 positions worth $324M, down 5.6% from $344M the previous quarter. Its ten largest holdings account for 69% of the portfolio.
Covenant Partners withdrew a net $15M in Q4 2024, closing 30 positions and reducing 72 holdings. Its most notable exit was Merck, an estimated $1.34M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.6% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Covenant Partners opened a new position in Carlyle Group worth $309K.
- Covenant Partners's largest Q4 2024 buy was Carlyle Group: 6,129 shares worth $309K.
- Covenant Partners added most to iShares MSCI EAFE Value ETF in Q4 2024, an estimated $2.11M increase.
- Covenant Partners's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $4.04M.
- Covenant Partners fully exited Merck in Q4 2024, selling an estimated $1.34M.
- Covenant Partners's ten largest holdings make up 69% of its $324M portfolio in Q4 2024.
- Covenant Partners opened 7 new positions and closed 30 in Q4 2024.
- Covenant Partners's portfolio value fell 5.6% quarter-over-quarter to $324M.
Based on Covenant Partners's 13F filing for Q4 2024, filed 14 Feb 2025.